Prof. Bahman Anvari

Prof. Anvari has been engaged in the field of biophotonics for nearly 20 years. As a postdoctoral Fellow and later a Research Associate at the Beckman Laser Institute & Medical Clinic (1993-1997) at University of California (UC), Irvine, he contributed to the development of the cryogenic spray cooling (CSC) technology for use in conjunction with laser treatment of port wine stains (PWSs). Dr. Anvari is a co-inventor on some of the patents related to CSC technology, which have been licensed and commercialized by Candela Corporation, a leading manufacturer of lasers utilized in dermatology for treatment of various cutaneous disorders including PWSs. He performed theoretical analyses, conducted ex-vivo, animal model, and human studies that laid the groundwork for application of CSC in conjunction with laser irradiation, which is one of the current standards of care in clinical management of PWS patients worldwide. The CSC technology has consistently been among the UC Top-Earning Inventions. According to UC Technology Transfer Annual Reports, the total royalty generated through this technology has been more than $45 million for fiscal years 2003-2010. Dr. Anvari’s efforts led to three major research grants from NSF (CBET-9634110), National Institute of Heart, Lung, and Blood (R15-HL058215), and The Whitaker Foundation awarded to him as the PI. He joined the Department of Bioengineering at Rice University in 1998 as an Assistant Professor and continued his research on PWS phototherapy, which was further funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, (1R01-AR47996), and Texas Higher Education Coordinating Board and Candela Corporation. At Rice, he expanded his research activities into engineering of nano-constructs as exogenous chromophores for near infrared imaging and phototherapy, and became an Associate Professor in 2003. Dr. Anvari moved to the Bioengineering Department at UC Riverside as a Professor in 2006 where he continues his research activities on the use of nano-constructs composed of biological materials for biomedical applications. His research on the use of nano-constructs composed of a genome-depleted plant infecting virus doped with the FDA-approved chromophore, indocyanine green (ICG) for potential imaging of peritoneal ovarian cancers during intraoperative surgery is currently funded by an NSF grant (CBET-1144237). In recognition of his accomplishments, Dr. Anvari was inducted into the American Institute for Medical and Biological Engineering (AIMBE) as a Fellow for pioneering research and development of laser-based technologies that are widely used for clinical treatment of selected dermatological procedures in 2008, and elected as a Fellow of the American Association for the Advancement of Science (AAAS) for distinguished contributions to the field of biophotonics, particularly for development of technologies aimed at photoremediation of tissue malformations and cellular biophysical analysis in 2010.

Prof. Anvari's Profile at UC Riverside

This email address is being protected from spambots. You need JavaScript enabled to view it.